Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The non-specific oral microbiota and dental enamel represent a complex biological interface rather than a single molecular target. The oral microbiota consists of a diverse community of over 700 species of bacteria, fungi, and viruses that form biofilms on tooth surfaces (Dewhirst et al., 2010, Journal of Bacteriology). Dental enamel is the highly mineralized outer layer of the tooth, primarily composed of hydroxyapatite crystals (StatPearls, 2023). In a healthy state, the microbiota exists in symbiosis; however, dysbiosis can lead to the overgrowth of acidogenic species that ferment dietary sugars to produce organic acids. These acids lower the local pH, causing the demineralization of the enamel and leading to dental caries (NIH/NIDCR, 2021). Therapeutic interventions typically involve non-specific antimicrobials to reduce microbial load or mineralizing agents like fluoride that promote the formation of acid-resistant fluorapatite (CDC, 2023). Because this target encompasses an entire ecosystem and a structural tissue, it is considered a physiological system rather than a discrete pharmacological receptor.
Drugs targeting this system act through the non-specific antimicrobial inhibition of bacterial growth, disruption of biofilm architecture, or by promoting the remineralization of the enamel hydroxyapatite lattice to form acid-resistant fluorapatite.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific oral microbiota and dental enamel.